Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
Agriculture and Agri-Food Canada, Lethbridge Research Station, 5403 1st Ave South, Lethbridge, Alberta, Canada, T1J 4B1.
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:13-29. doi: 10.1016/j.ijpddr.2019.09.001. Epub 2019 Sep 9.
We have undertaken a detailed analysis of the biotransformation of five of the most therapeutically important benzimidazole anthelmintics - albendazole (ABZ), mebendazole (MBZ), thiabendazole (TBZ), oxfendazole (OxBZ) and fenbendazole (FBZ) - in Caenorhabditis elegans and the ruminant parasite Haemonchus contortus. Drug metabolites were detected by LC-MS/MS analysis in supernatants of C. elegans cultures with a hexose conjugate, most likely glucose, dominating for all five drugs. This work adds to a growing body of evidence that glucose conjugation is a major pathway of xenobiotic metabolism in nematodes and may be a target for enhancement of anthelmintic potency. Consistent with this, we found that biotransformation of albendazole by C. elegans reduced drug potency. Glucose metabolite production by C. elegans was reduced in the presence of the pharmacological inhibitor chrysin suggesting that UDP-glucuronosyl/glucosyl transferase (UGT) enzymes may catalyze benzimidazole glucosidation. Similar glucoside metabolites were detected following ex vivo culture of adult Haemonchus contortus. As a step towards identifying nematode enzymes potentially responsible for benzimidazole biotransformation, we characterised the transcriptomic response to each of the benzimidazole drugs using the C. elegans resistant strain CB3474 ben-1(e1880)III. In the case of albendazole, mebendazole, thiabendazole, and oxfendazole the shared transcriptomic response was dominated by the up-regulation of classical xenobiotic response genes including a shared group of UGT enzymes (ugt-14/25/33/34/37/41/8/9). In the case of fenbendazole, a much greater number of genes were up-regulated, as well as developmental and brood size effects suggesting the presence of secondary drug targets in addition to BEN-1. The transcriptional xenobiotic response of a multiply resistant H. contortus strain UGA/2004 was essentially undetectable in the adult stage but present in the L3 infective stage, albeit more muted than C. elegans. This suggests that xenobiotic responses may be less efficient in stages of parasitic nematodes that reside in the host compared with the free-living stages.
我们对五种最具治疗意义的苯并咪唑类驱虫药——阿苯达唑(ABZ)、甲苯咪唑(MBZ)、噻苯达唑(TBZ)、奥芬达唑(OxBZ)和芬苯达唑(FBZ)——在秀丽隐杆线虫和反刍动物寄生虫捻转血矛线虫中的生物转化进行了详细分析。采用 LC-MS/MS 分析在秀丽隐杆线虫培养物上清液中检测到药物代谢物,所有五种药物均以六碳糖缀合物为主,最可能是葡萄糖。这项工作增加了越来越多的证据,证明葡萄糖缀合是线虫中外源生物代谢的主要途径,可能是增强驱虫药效力的靶点。与此一致的是,我们发现秀丽隐杆线虫对阿苯达唑的生物转化降低了药物的效力。在药理学抑制剂白杨素存在的情况下,秀丽隐杆线虫葡萄糖代谢产物的产生减少,这表明 UDP-葡糖醛酸基/葡糖苷基转移酶(UGT)酶可能催化苯并咪唑的葡糖苷化。在体外培养成年捻转血矛线虫后,也检测到类似的糖苷代谢物。为了鉴定可能负责苯并咪唑生物转化的线虫酶,我们使用抗药性秀丽隐杆线虫 CB3474 ben-1(e1880)III 对每种苯并咪唑药物进行了转录组特征分析。对于阿苯达唑、甲苯咪唑、噻苯达唑和奥芬达唑,共同的转录组反应主要由经典的外源生物反应基因上调主导,包括一组共同的 UGT 酶(ugt-14/25/33/34/37/41/8/9)。对于芬苯达唑,上调的基因数量更多,同时还存在发育和产卵大小效应,这表明除了 BEN-1 之外,还存在其他次要的药物靶点。多耐药捻转血矛线虫 UGA/2004 菌株的转录外源生物反应在成虫阶段基本上无法检测到,但在 L3 感染阶段存在,尽管比秀丽隐杆线虫的反应更弱。这表明与自由生活阶段相比,寄生虫线虫在宿主中所处的阶段,对外源生物的反应可能效率较低。